Mapping of m6A and Its Regulatory Targets in Prostate Cancer

Published: 3 November 2020| Version 1 | DOI: 10.17632/xv2vzc8pzz.1
Contributor:
Kellie Cotter

Description

Genomic and transcriptomic alterations are insufficient to explain the variance in protein expression seen in cancer. Recent evidence has highlighted the role of N6-methyladenosine (m6A) in the regulation of mRNA expression, stability and translation, supporting a potential role for post-transcriptional regulation mediated by m6A in cancer. Here we explore prostate cancer as an exemplar cancer and generate the first prostate m6A maps, and further examined how low levels of N6-adenosine-methyltransferase (METTL3) associates with advanced prostate cancer and results in altered expression at the level of transcription, translation, and protein.

Files